Definitive Healthcare targets $220M–$222M FY2026 revenue

Definitive Healthcare told investors on its Q2 2026 earnings call that it is aiming for fiscal 2026 revenue of $220 million to $222 million. Company officials presented that range as the foundation for their FY2026 outlook and said discussions of adjusted profitability measures did not alter the top-line assumptions.

On the same call, management also set an expected timeline for product rollout, saying the Turbo AI platform is planned to reach general availability before December 31, 2026. Officials described Turbo as a next-generation AI offering targeted at life-sciences customers and framed the general-availability milestone as a key commercial step.

Turbo AI timeline set, but revenue impact not quantified

While the company linked Turbo’s broader release to While the company linked Turbo’s broader release to commercialization progress, officials did not provide a specific FY2026 revenue contribution for the platform. Management said commercialization work is expected to continue through the remainder of the year, indicating that preparations for wider availability are still underway.

Officials signaled that investors will be watching closely for confirmation that Turbo reaches the market by the stated deadline of December 31, 2026. They also suggested that market participants may focus on whether management updates guidance after the platform becomes commercially available, given that the current fiscal outlook does not attach a numerical uplift tied to Turbo.

The materials discussed did not include an immediate market reaction. Officials characterized reaction as pending.

Demand and budget-cycle risks highlighted for FY2026

They said these elements could affect purchasing decisions

Company officials pointed to uncertainty in life-sciences demand conditions as a risk factor, alongside the timing of customer budget cycles. They said these elements could affect purchasing decisions and influence how quickly new offerings are adopted during fiscal 2026.

Management outlined a range of potential outcomes tied to Turbo’s adoption path. Officials said that broad adoption could lift average revenue per user and open additional cross-sell opportunities, while slower adoption or expensive integration could pressure near-term margins.

Even as the company discussed adjusted profitability metrics, officials said the revenue range of $220 million to $222 million was not revised during the call. With Turbo’s 2026 revenue contribution left unquantified, the FY2026 guidance remains anchored to the stated top-line target and the timetable for general availability, alongside the risks management associated with sector demand and customer budget timing.